A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
Clinical trial NCT03192176 · COMPLETED
Trial details
- NCT number
- NCT03192176
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-19
- Primary completion
- 2018-09-19
- Enrollment
- 356
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.